Abman SH - Search Results

1

Effects of sildenafil on pulmonary hypertension and exercise tolerance in severe cystic fibrosis-related lung disease.

Montgomery GS, Sagel SD, Taylor AL, Abman SH. Montgomery GS, et al. Among authors: abman sh. Pediatr Pulmonol. 2006 Apr;41(4):383-5. doi: 10.1002/ppul.20393. Pediatr Pulmonol. 2006. PMID: 16479610

2

Early respiratory course in infants with cystic fibrosis: relevance to newborn screening.

Accurso FJ, Sokol RJ, Hammond KB, Abman SH. Accurso FJ, et al. Among authors: abman sh. Pediatr Pulmonol Suppl. 1991;7:42-5. doi: 10.1002/ppul.1950110709. Pediatr Pulmonol Suppl. 1991. PMID: 1782128 Review.

3

Fat-soluble vitamins in infants identified by cystic fibrosis newborn screening.

Sokol RJ, Reardon MC, Accurso FJ, Stall C, Narkewicz MR, Abman SH, Hammond KB. Sokol RJ, et al. Among authors: abman sh. Pediatr Pulmonol Suppl. 1991;7:52-5. doi: 10.1002/ppul.1950110711. Pediatr Pulmonol Suppl. 1991. PMID: 1782131

4

Pulmonary vascular extraction of circulating norepinephrine in infants with bronchopulmonary dysplasia.

Abman SH, Schaffer MS, Wiggins J, Washington R, Manco-Johnson M, Wolfe RR. Abman SH, et al. Pediatr Pulmonol. 1987 Nov-Dec;3(6):386-91. doi: 10.1002/ppul.1950030603. Pediatr Pulmonol. 1987. PMID: 3696807

5

New developments in the pathogenesis and treatment of neonatal pulmonary hypertension.

Abman SH. Abman SH. Pediatr Pulmonol Suppl. 1999;18:201-4. Pediatr Pulmonol Suppl. 1999. PMID: 10093143 Review. No abstract available.

6

Infant lung function after inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn.

Dobyns EL, Griebel J, Kinsella JP, Abman SH, Accurso FJ. Dobyns EL, et al. Among authors: abman sh. Pediatr Pulmonol. 1999 Jul;28(1):24-30. doi: 10.1002/(sici)1099-0496(199907)28:1<24::aid-ppul5>3.0.co;2-m. Pediatr Pulmonol. 1999. PMID: 10406047 Clinical Trial.

7

Congenital pulmonary venous stenosis presenting as persistent pulmonary hypertension of the newborn.

Holcomb RG, Tyson RW, Ivy DD, Abman SH, Kinsella JP. Holcomb RG, et al. Among authors: abman sh. Pediatr Pulmonol. 1999 Oct;28(4):301-6. doi: 10.1002/(sici)1099-0496(199910)28:4<301::aid-ppul10>3.0.co;2-m. Pediatr Pulmonol. 1999. PMID: 10497380 Review.

8

NO pathway in CF and non-CF children.

Wooldridge JL, Deutsch GH, Sontag MK, Osberg I, Chase DR, Silkoff PE, Wagener JS, Abman SH, Accurso FJ. Wooldridge JL, et al. Among authors: abman sh. Pediatr Pulmonol. 2004 Apr;37(4):338-50. doi: 10.1002/ppul.10455. Pediatr Pulmonol. 2004. PMID: 15022131

9

Pulmonary hypertension in children: a historical overview.

Abman SH. Abman SH. Pediatr Crit Care Med. 2010 Mar;11(2 Suppl):S4-9. doi: 10.1097/PCC.0b013e3181c765f3. Pediatr Crit Care Med. 2010. PMID: 20216162 Review.

10

Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.

Abman SH, Kinsella JP, Rosenzweig EB, Krishnan U, Kulik T, Mullen M, Wessel DL, Steinhorn R, Adatia I, Hanna B, Feinstein J, Fineman J, Raj U, Humpl T; Pediatric Pulmonary Hypertension Network (PPHNet). Abman SH, et al. Am J Respir Crit Care Med. 2013 Mar 15;187(6):572-5. doi: 10.1164/rccm.201210-1928PP. Epub 2012 Dec 6. Am J Respir Crit Care Med. 2013. PMID: 23220921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

455 results

Search Page